COLL
Collegium Pharmaceutical Inc
22.80$
-1.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,819.8% | +65.8% | -16.3% | +114.8% | +5.2% | +110.2% | +7.5% | +69.7% | -2.6% | +45.5% | -0.4% | |
| – | +2,054.9% | +63.7% | -15.8% | +77.9% | +7.7% | +8.7% | +13.6% | +33.1% | +28.0% | -10.3% | +43.4% | |
| – | +5,756.6% | +60.1% | -22.5% | +23.5% | +15.9% | +2.4% | +7.1% | -6.8% | +37.6% | -70.5% | +255.8% | |
| – | +5,756.6% | +60.1% | -22.5% | +23.5% | +15.9% | +2.4% | +7.1% | -6.8% | +78.8% | -47.6% | +149.8% | |
| – | – | – | +368.2% | +681.9% | -6.4% | +14.2% | +27.0% | +73.0% | -2.0% | +27.3% | -7.5% | |
| – | -100.0% | – | +37.8% | +331.2% | +23.4% | +61.9% | +11.4% | +167.3% | -30.5% | +10.0% | +15.1% | |
| – | +43.6% | +40.7% | +75.9% | +407.9% | +125.4% | -9.2% | +2.6% | +0.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | +0.1% | +21.3% | -10.1% | |
| – | -100.0% | – | -100.0% | – | -33.3% | +1,038.5% | -20.0% | +111.2% | -25.7% | +111.4% | -24.9% | |
| – | -27.0% | +114.4% | +16.2% | +534.1% | +9.6% | +109.2% | +6.8% | +100.2% | -3.2% | +51.4% | -5.5% | |
| – | -44.7% | +297.7% | +37.3% | +495.4% | +7.6% | +18.7% | +16.8% | +55.1% | +5.6% | +11.3% | -13.6% | |
| – | -56.9% | +0.0% | -44.5% | +11.0% | +173.4% | +974.3% | +2.0% | +232.8% | +12.7% | -64.3% | -53.8% | |
| – | +161.1% | +212.0% | -68.4% | +113.8% | -48.6% | +60.3% | -58.2% | -16.6% | +148.8% | -54.7% | +170.9% | |
| – | -39.1% | -64.3% | -100.0% | – | -22.2% | +2,633.7% | -3.8% | +167.0% | -10.1% | +62.8% | -1.0% | |
| – | – | +58.6% | -22.9% | -12.0% | -4.5% | +112.8% | +9.1% | -4.0% | +0.3% | +17.1% | +31.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +81.3% | +79.2% | +24.7% | +8.9% | +1.5% | +5.1% | +16.8% | -17.6% | +23.5% | -3.3% | -1.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.